As per MRFR analysis, the South Korea Gene Therapy Market Size was estimated at 129 (USD Million) in 2024.The South Korea Gene Therapy Market Industry is expected to grow from 145.4(USD Million) in 2025 to 612 (USD Million) by 2035. The South Korea Gene Therapy Market CAGR (growth rate) is expected to be around 13.958% during the forecast period (2025 - 2035)
Key South Korea Gene Therapy Market Trends Highlighted
The South Korea gene therapy market is witnessing significant growth driven by several key market drivers. One of the primary factors is the country's robust focus on biotechnology and medical research, which has led to substantial investments in innovative treatments. The South Korean government has launched initiatives to promote the development and commercialization of gene therapies, aiming to enhance healthcare outcomes while establishing the region as a leader in biopharmaceutical technology.
Moreover, the rising prevalence of genetic disorders and chronic diseases is increasing the demand for advanced therapeutic options, highlighting the urgency for effective gene therapies.There are numerous opportunities to be explored in the South Korea gene therapy market. The government’s support for local biotech companies through funding programs and incentives encourages collaboration between research institutions and private entities. This collaboration is fostering an environment where new treatment modalities can be rapidly developed and brought to market.
Additionally, as regulatory frameworks are evolving to be more accommodating for gene therapy approvals, this opens up avenues for novel therapies to reach patients quicker. Trends in recent times show a marked increase in clinical trials focusing on rare diseases and inherited genetic disorders within South Korea, propelled by advancements in precision medicine.The presence of leading research institutions and universities in the country enhances the innovation landscape, making it an attractive destination for international partnerships.
Furthermore, advancement in technologies such as CRISPR and viral vector development are leading to breakthroughs that could change treatment paradigms. The integration of artificial intelligence in gene therapy research is also becoming a focal point, helping to streamline processes and improve outcomes, indicating a future where personalized medicine is within reach for many more patients in South Korea.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
South Korea Gene Therapy Market Drivers
Increasing Investment in Research and Development
The South Korea Gene Therapy Market Industry is experiencing a surge in investment towards Research and Development (R&D), driven by both governmental initiatives and private sector funding. The South Korean government has earmarked significant financial resources for biopharmaceutical innovations, including gene therapy, recognizing its potential to provide advanced medical solutions for various diseases. For instance, the Ministry of Health and Welfare has launched initiatives aimed at enhancing healthcare technologies which designate substantial funds that could account for a yearly increase of 15% in R&D spending specific to gene therapy.
This proactive approach showcases the commitment of both public and private organizations, such as Samsung Biologics and Hanmi Pharmaceutical, who have intensified their efforts in developing novel gene-based therapies. Additionally, the increasing number of clinical trials in the region, supported by the Korea National Enterprise for Clinical Trials, emphasizes the flourishing environment for innovation, leading to a projected growth in the South Korea Gene Therapy Market Industry as advanced treatments become available.
Rising Incidence of Genetic Disorders
The increase in the incidence of genetic disorders in South Korea is a significant driver impacting the South Korea Gene Therapy Market Industry. With a reported rise of approximately 20% in genetic disorders over the past decade, including conditions such as hemophilia and cystic fibrosis, the demand for effective gene therapy solutions is paramount. The Korea Centers for Disease Control and Prevention has documented these figures, highlighting the necessity for innovative therapies that can address these complex health issues.
With the increase in the average age of the population and the prevalence of certain genetic conditions, organizations like LG Chem and Green Cross Laboratory are more focused on developing individual gene therapies, which in turn is driving market growth due to these healthcare needs. This is likely to accelerate the regional incorporation and introduction of gene therapies.
Supportive Regulatory Framework
The supportive regulatory framework for gene therapies in South Korea significantly contributes to the growth of the South Korea Gene Therapy Market Industry. The South Korean Ministry of Food and Drug Safety (MFDS) has implemented expedited approval processes for innovative therapies, ensuring that new gene treatments reach the market more rapidly. This framework includes provisions for conditional approvals and priority reviews for therapies that address unmet medical needs.
For example, the recent approval of a gene therapy for adenosine deaminase deficiency marked a pivotal moment in the adoption of such technologies, illustrating the government's commitment to fostering a pro-innovation environment. Moreover, the MFDS has been encouraging collaborations between domestic biotech firms and international companies, which not only enhances knowledge transfer but also accelerates the development of new options within the market.
Growing Partnership Trends
The trend of growing partnerships and collaborations between biotechnology companies and research institutions is a critical driver influencing the South Korea Gene Therapy Market Industry. Notable collaborations between domestic firms like SK Biopharmaceuticals and international biotechnology companies have paved the way for significant advancements in gene therapy research and development. The collaborative agreements often aim to leverage combined expertise to expedite clinical trials and improve therapeutic outcomes.
Furthermore, these partnerships facilitate access to additional funding sources and cutting-edge technologies, positioning South Korea as a hub for gene therapy innovation. The presence of esteemed academic institutions such as Seoul National University, which actively engages in gene therapy research, contributes to a robust ecosystem conducive to collaboration and knowledge sharing, thus propelling the market's growth trajectory.
South Korea Gene Therapy Market Segment Insights
Gene Therapy Market Therapeutic Area Insights
The South Korea Gene Therapy Market, particularly within the Therapeutic Area segment, showcases a rapidly evolving landscape driven by advancements in biomedicine and technological innovations. With a growing focus on precision medicine, gene therapy presents a promising avenue for treatment within various therapeutic applications, primarily in Oncology, Genetic Disorders, Infectious Diseases, Cardiovascular Diseases, and Neurological Disorders.
Oncology occupies a significant space in this market due to the increasing incidence of various cancers, pushing continuous demand for targeted therapies that can effectively address specific genetic mutations associated with tumors. Genetic Disorders also represent a crucial area, as gene therapy holds the potential to rectify hereditary conditions by correcting genetic defects at their source, greatly improving patient quality of life.
Infectious Diseases continue to gain attention as researchers explore gene therapy's capabilities in developing vaccines and treatments, particularly in response to emerging viral outbreaks. Similarly, Cardiovascular Diseases are increasingly seen as a major target due to the prevalence of conditions linked to genetic predispositions, thereby creating opportunities for innovative therapeutic methods aimed at repairing or replacing damaged cardiac tissues. Neurological Disorders present another challenging domain where gene therapy could bring breakthroughs in treating complex conditions such as Alzheimer’s disease, Parkinson's disease, and spinal muscular atrophy.
The therapeutic potential in these areas is underscored by ongoing Research and Development initiatives, fostered by supportive governmental policies in South Korea that encourage biomedical innovation and streamline regulatory processes for introducing new therapies into the market. This confluence of demand, innovation, and supportive infrastructure positions the South Korea Gene Therapy Market as a growing force in the healthcare industry, with substantial investment opportunities aligned with unmet medical needs across these critical therapeutic areas.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Gene Therapy Market Technology Insights
The Technology segment of the South Korea Gene Therapy Market plays a crucial role in shaping the landscape of modern therapeutics. With significant focus on advanced modalities such as Viral Vectors, CRISPR, Gene Editing, RNA Therapy, and Non-Viral Methods, this segment has become a cornerstone for innovation and development in gene therapy. Viral Vectors are widely recognized for their effectiveness in delivering therapeutic genes into target cells, making them essential for successful treatment outcomes.
Similarly, CRISPR technology has revolutionized the field by providing precise gene editing capabilities, enabling researchers to manipulate genetic material with unprecedented accuracy.The Gene Editing technology category is rapidly evolving, supporting the development of new therapies for genetic disorders. RNA Therapy has gained traction due to its potential in treating a wide range of diseases by modulating gene expression, while Non-Viral Methods are increasingly popular for their safety and efficiency, allowing for innovative approaches to gene delivery.
Collectively, these technologies drive the South Korea Gene Therapy Market forward, addressing various unmet medical needs and paving the way for future advancements in personalized medicine and therapeutic interventions.As the market continues to grow, investments in Research and Development are vital to overcoming challenges and harnessing the full potential of these transformative technologies.
Gene Therapy Market Application Insights
The South Korea Gene Therapy Market has witnessed significant growth in its Application segment, encompassing Research, Clinical, and Commercial areas. The nation has positioned itself as a leader in biotechnology, supported by strong government initiatives such as the "K-Bio" strategy, which promotes innovative research and development in gene therapy. The Research aspect is crucial as it drives the discovery and development of novel therapeutic techniques, addressing genetic disorders and advancing personalized medicine.
The Clinical application is imperative for translating innovative research findings into practical treatments, with numerous ongoing clinical trials focusing on a wide range of diseases, highlighting its importance in healthcare delivery.In the Commercial domain, gene therapies are becoming increasingly accessible to patients, opened by various partnerships and collaborations between biopharmaceutical companies and research institutions.
This dynamic encourages more investments, accelerates market growth, and enhances patient outcomes, making the Application segment a pivotal factor in the overall landscape of the South Korea Gene Therapy Market. As such, continuous innovations and collaborations are likely to sustain the momentum of growth in this segment.
Gene Therapy Market Route of Administration Insights
The South Korea Gene Therapy Market exhibits a diverse range of delivery mechanisms under the Route of Administration segment, which significantly influences treatment effectiveness and patient compliance. Intravenous administration is crucial due to its rapid systemic distribution, making it an essential method for treating various genetic disorders. Intramuscular routes receive attention for their ease of administration and potential for self-administration, which broadens accessibility for patients. Intradermal methods show promise for localized treatments, particularly for skin-related genetic issues, while intrathecal delivery is critical for targeting central nervous system disorders, ensuring that therapeutic agents effectively reach specific neural tissues.
Oral administration's versatility and potential for patient comfort make it an appealing choice, possibly enhancing adherence to treatment protocols. The combination of these various routes highlights the market's adaptability and responsiveness to patient needs within South Korea, driven by advances in technology and evolving healthcare policies that aim to improve patient outcomes and drive market growth. As the healthcare landscape continues to adapt, these routes play a significant role in shaping the development and delivery of innovative gene therapies, reflecting both market trends and unique regional healthcare dynamics.
South Korea Gene Therapy Market Key Players and Competitive Insights
The South Korea Gene Therapy Market is witnessing a dynamic and competitive landscape characterized by rapid advancements in technology, increasing investments in research and development, and a growing focus on personalized medicine. The market reflects a strong emphasis on innovative therapies aimed at treating genetic disorders, cancers, and rare diseases. Several players are leveraging breakthrough technologies, including CRISPR and AAV vectors, to develop novel gene therapies that promise improved outcomes. The regulatory environment in South Korea is also evolving to support the development and commercialization of gene therapies, which is enhancing the competitive atmosphere.
As a result, companies are now focusing on collaboration, partnerships, and strategic alliances to capitalize on emerging opportunities and navigate challenges inherent in the development of gene therapeutics.Amgen has established a strong presence in the South Korea Gene Therapy Market, driven by its innovative research portfolio focusing on advanced therapeutic solutions. The company has emphasized the integration of biotechnology with gene therapy principles that align with the region's healthcare needs. Amgen’s strengths lie in its robust pipeline of treatment candidates targeting various genetic conditions and diseases, along with its commitment to precision medicine. The company has invested significantly in local collaborations that enhance its operational capabilities and market reach, demonstrating its dedication to the South Korean market.
This emphasis on partnerships not only accelerates the development of potential therapies but also enhances patient accessibility to innovative treatments, thereby strengthening Amgen's brand and market position in South Korea.Genethon is a prominent player within the South Korea Gene Therapy Market, recognized for its contributions to the development of therapies aimed at rare genetic disorders. The company focuses on advanced gene therapy techniques, leveraging its expertise to create effective treatment options. Genethon has established strategic alliances with local academic and healthcare institutions, facilitating knowledge exchange and research collaboration that is crucial for accelerating therapy development.
The company is known for its leading products and research initiatives, making significant strides in the commercialization of gene therapies targeted for various conditions prevalent within South Korea. Genethon's commitment to innovation is further highlighted through key mergers and acquisitions that bolster its R&D capabilities, enhancing its ability to deliver cutting-edge therapies that meet the unique healthcare needs of the South Korean population.
Key Companies in the South Korea Gene Therapy Market Include
South Korea Gene Therapy Market Industry Developments
The South Korea Gene Therapy Market has witnessed significant developments recently, with Amgen and GSK focusing on expanding their presence through enhanced research initiatives. In October 2023, Samsung Biologics announced a substantial investment aimed at increasing its manufacturing capabilities for gene therapy products, reflecting the growing demand in the region. There has been a notable rise in the market valuation of companies such as LG Chem and BristolMyers Squibb, driven by their advancements in gene editing techniques and successful clinical trials. In terms of mergers and acquisitions, Genzyme acquired notable gene therapy assets from Sangamo Therapeutics in September 2023, further consolidating its position in the market.
Recent statistics indicate that South Korea's government is prioritizing biopharmaceuticals as a key growth sector, pledging additional support for Research and Development projects. Over the last two to three years, the gene therapy landscape has gained heightened attention, with regulatory approvals accelerating for therapies addressing rare diseases. The increased collaboration among major players like Roche and Novartis has also stimulated innovation, promoting South Korea as a vital hub for gene therapy research and development in the Asia-Pacific region.
South Korea Gene Therapy Market Segmentation Insights
Gene Therapy Market Therapeutic Area Outlook
Gene Therapy Market Technology Outlook
Gene Therapy Market Application Outlook
Gene Therapy Market Route of Administration Outlook
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 129.0(USD Million) |
| MARKET SIZE 2024 | 145.4(USD Million) |
| MARKET SIZE 2035 | 612.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 13.958% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Amgen, Genethon, Bluebird Bio, BristolMyers Squibb, Sangamo Therapeutics, Genzyme, Samsung Biologics, Roche, GSK, Medgene, Spark Therapeutics, Hana Biosciences, LG Chem, Novartis, AbbVie |
| SEGMENTS COVERED | Therapeutic Area, Technology, Application, Route of Administration |
| KEY MARKET OPPORTUNITIES | Innovative treatment for rare diseases, Expanding regulatory support and incentives, Growing public-private partnerships, Increasing patient awareness and access, Advancements in CRISPR technology |
| KEY MARKET DYNAMICS | Regulatory support, Increasing R&D investments, Rising incidence of genetic disorders, Expanding healthcare infrastructure, Growing patient awareness |
| COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The South Korea Gene Therapy Market is expected to be valued at 145.4 million USD in 2024.
By 2035, the South Korea Gene Therapy Market is projected to reach 612.0 million USD.
The expected CAGR for the South Korea Gene Therapy Market from 2025 to 2035 is 13.958%.
In 2024, the oncology therapeutic area is expected to hold the largest market share, valued at 42.0 million USD.
The market size for genetic disorders in the South Korea Gene Therapy Market is expected to be 36.2 million USD in 2024.
Major players in the market include Amgen, Genethon, Bluebird Bio, Bristol-Myers Squibb, and Sangamo Therapeutics.
By 2035, the infectious diseases therapeutic area is expected to grow to 116.6 million USD.
The projected market size for cardiovascular diseases is expected to be 22.3 million USD in 2024.
Key trends include advancements in gene editing technologies and increasing research investment in therapeutic applications.
The neurological disorders segment is projected to reach 85.8 million USD by 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
